Corpus ID: 22621901

[Paquid 2012: illustration and overview].

  title={[Paquid 2012: illustration and overview].},
  author={J. Dartigues and C. Helmer and L. Letenneur and K. P{\'e}r{\`e}s and H. Ami{\`e}va and S. Auriacombe and J. Orgogozo and D. Commenges and H. Jacqmin-Gadda and S. Richard-Harston and F. Delva and A. Foubert‐Samier and P. Barberger‐Gateau},
  journal={Geriatrie et psychologie neuropsychiatrie du vieillissement},
  volume={10 3},
Paquid (personnes âgées quid) is a population-based cohort specifically designed to study the epidemiology of brain aging and dependency in activities of daily living in elderly people. At baseline screening, 3.777 subjects older than 65 were randomly selected in 75 different parishes from Gironde and Dordogne, and two administrative districts around Bordeaux in South-Western France. The participation rate was 68%. Subjects were followed up every two to three years with repeated measures of… Expand
Burden of disease due to dementia in the elderly population of Korea: present and future
Dementia has the highest burden of disease in the elderly Korean population, and this burden will increase sharply with the aging of the population, by applying demographic structure projections in terms of 5-year age groups in Korea from 2010 to 2050. Expand
Do partners of severely disabled elderly protect against nursing home entry? Evidence from a French cohort
The low protective effect of partners against the risk of nursing home entry for the oldest-old or severely disabled should lead to a reassessment of the relevance of informal support for this specific group of individuals. Expand
French cross-cultural adaptation and validation of the Quality of Life-Alzheimer's Disease scale in Nursing Homes (QOL-AD NH)
Background No specific scale to measure Quality of Life in Alzheimer's Disease in Nursing Homes (QoL-AD NH) exists in French. We aimed to translate and culturally adapt the QoL-AD NH participantExpand
Rythme veille-sommeil et état de vigilance : influence sur l’évaluation cognitive des sujets Alzheimer
Cette etude vise a demontrer l’influence des troubles du sommeil et de l’etat de vigilance sur les performances cognitives des personnes atteintes de la maladie d’Alzheimer, posant alors question surExpand
Sevrage des hypnotiques chez la personne âgée en institution : spécificité du cadre institutionnel, outil d'aide diagnostique et thérapeutique
Les etudes ont demontre la faisabilite et l'interet d'un sevrage des hypnotiques chez la personne âgee, avec un effet benefique sur les risques de chute, la somnolence diurne, les troubles cognitifs,Expand
La prise en soin de la fin de vie des patients atteints de troubles neurocognitifs sévères par les médecins généralistes : une enquête auprès des médecins généralistes du Finistère
Introduction : les maladies neurodegeneratives comme la Maladie d'Alzheimer (MA) sont actuellement incurables et evoluent vers la dependance. Avec le vieillissement de la population, le medecinExpand


Dementia in Subjects Aged 75 Years or Over within the PAQUID Cohort: Prevalence and Burden by Severity
The results confirm the high prevalence of dementia in subjects aged over 75 and illustrate the devastating consequences of this disease in terms of disability and institutionalization. Expand
Fish, meat, and risk of dementia: cohort study
All the participants who had lost three points or more on the mini-mental state examination since a previous visit or were suspected of having dementia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, third edition, revised (DSM-III-R) were visited by a neurologist to confirm the diagnosis. Expand
Prévalence de la démence et de la maladie d'Alzheimer chez les personnes de 75 ans et plus : données réactualisées de la cohorte PAQUID
The results point out the importance of regarding dementia as a Public Health priority and of developing necessary measures for caring for these subjects, whether residing in their home or an institution. Expand
Primary and Secondary Care Consultations in Elderly Demented Individuals in France
The failure to see a physician due to dementia, especially secondary-care practitioners, is frequent in the community, particularly in the oldest subjects. Expand
[Alzheimer disease and other dementia in France: Identification, management and neuroleptic use (2007-2009)].
Increased use of neuroleptic was associated with hospitalisation in a community hospital, the number of general practitioner consultation and an age between 60 and 75 years, and at least one liberal psychiatrist consultation decreased the use. Expand
Flavonoid intake and cognitive decline over a 10-year period.
It is raised the possibility that dietary flavonoid intake is associated with better cognitive evolution, as well as several other potential confounders, after adjustment for age, sex, and educational level. Expand
The prevalence of dementia and Alzheimer's disease in Shanghai, China: Impact of age, gender, and education
The findings indicate that the prevalence of dementia in Shanghai is very much higher than figures published earlier for China and Japan, and at the lower part of the range of values reported for community residents in the United States and other Western countries, but less than half of that reported in the recently published survey of the elderly in East Boston. Expand
The 9 year cognitive decline before dementia of the Alzheimer type: a prospective population-based study.
It is shown that abnormally low performances can be evidenced 9 years before the clinical diagnosis of Alzheimer's disease in several domains of cognition beyond memory and that cognitive change over time can be influenced by education. Expand
Depressive symptomatology and cognitive functioning: an epidemiological survey in an elderly community sample in France.
A significant association was found between CES-D and MMS scores, but after adjusting for age, living arrangements, and especially functional limitations, the relationship remained strong only for women. Expand
Risk factors for Alzheimer disease
In 3 articles appearing in this issue of Neurology ®, new risk factors for AD were proposed that involve new pathways and suggest innovative treatment strategies. Expand